OMERS ADMINISTRATION Corp Invests $5.67 Million in Cardinal Health, Inc. $CAH

OMERS ADMINISTRATION Corp bought a new stake in shares of Cardinal Health, Inc. (NYSE:CAH) in the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 23,861 shares of the company’s stock, valued at approximately $5,668,000.

Several other large investors also recently bought and sold shares of the business. University of Texas Texas AM Investment Management Co. purchased a new stake in Cardinal Health during the fourth quarter valued at $26,000. Bank of Jackson Hole Trust purchased a new position in shares of Cardinal Health in the 4th quarter worth $27,000. Jones Financial Companies Lllp increased its holdings in shares of Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after buying an additional 14,034 shares during the last quarter. Palladiem LLC bought a new stake in shares of Cardinal Health in the 4th quarter worth about $28,000. Finally, Indiana Trust & Investment Management Co purchased a new stake in shares of Cardinal Health during the 1st quarter valued at about $29,000. Institutional investors own 87.17% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently commented on CAH shares. Barclays increased their price target on shares of Cardinal Health from $258.00 to $275.00 and gave the company an “overweight” rating in a report on Thursday, August 13th. Wells Fargo & Company upped their price objective on Cardinal Health from $245.00 to $277.00 and gave the company an “overweight” rating in a research report on Wednesday, August 12th. Mizuho raised their price objective on Cardinal Health from $240.00 to $250.00 and gave the company an “outperform” rating in a research note on Wednesday, August 12th. Leerink Partners set a $292.00 target price on Cardinal Health in a report on Tuesday, August 11th. Finally, Weiss Ratings downgraded Cardinal Health from a “buy (b+)” rating to a “buy (b)” rating in a research report on Wednesday, August 19th. Sixteen equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $266.56.

Insider Activity

In other Cardinal Health news, CEO Jason M. Hollar sold 44,529 shares of the company’s stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $236.18, for a total value of $10,516,859.22. Following the transaction, the chief executive officer owned 190,603 shares of the company’s stock, valued at $45,016,616.54. This represents a 18.94% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CAO Mary C. Scherer sold 2,302 shares of the stock in a transaction on Wednesday, August 19th. The stock was sold at an average price of $237.39, for a total value of $546,471.78. Following the completion of the sale, the chief accounting officer owned 2,811 shares in the company, valued at approximately $667,303.29. The trade was a 45.02% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 210,271 shares of company stock worth $49,626,657 in the last three months. Corporate insiders own 0.12% of the company’s stock.

More Cardinal Health News

Here are the key news stories impacting Cardinal Health this week:

• Positive Sentiment: Cardinal Health’s specialty business remains a key growth driver, supporting the case for retaining CAH in portfolios. The company has also issued fiscal 2027 adjusted EPS guidance of $12.40–$12.60, broadly consistent with analyst expectations. Reasons to Retain Cardinal Health Stock in Your Portfolio for Now
• Positive Sentiment: Recent coverage highlights Cardinal Health’s efforts to expand its healthcare reach, potentially creating additional growth opportunities beyond its core pharmaceutical distribution operations. Why Is Cardinal Health Expanding Its Healthcare Reach?
• Positive Sentiment: Cardinal Health’s latest quarterly results provided support for the stock: earnings per share exceeded consensus estimates, while revenue increased year over year. The company’s medical and pharmaceutical services also remain central to its relative performance within the healthcare providers and services group. Winners and Losers of Q2: Cardinal Health vs. Healthcare Providers and Services Stocks

Cardinal Health Trading Up 1.1%

CAH stock opened at $232.13 on Tuesday. The stock has a market cap of $53.99 billion, a PE ratio of 32.11, a P/E/G ratio of 1.23 and a beta of 0.49. Cardinal Health, Inc. has a 12 month low of $145.87 and a 12 month high of $258.30. The company has a 50-day moving average price of $232.13 and a 200 day moving average price of $217.96.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings data on Tuesday, August 11th. The company reported $2.91 earnings per share for the quarter, topping analysts’ consensus estimates of $2.42 by $0.49. The company had revenue of $63.67 billion for the quarter, compared to analyst estimates of $65.15 billion. Cardinal Health had a net margin of 0.67% and a negative return on equity of 98.53%. The firm’s revenue for the quarter was up 5.8% on a year-over-year basis. During the same period in the prior year, the company posted $2.08 EPS. Cardinal Health has set its FY 2027 guidance at 12.400-12.600 EPS. Sell-side analysts forecast that Cardinal Health, Inc. will post 12.54 EPS for the current year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 15th. Stockholders of record on Thursday, October 1st will be issued a $0.5158 dividend. This represents a $2.06 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Thursday, October 1st. Cardinal Health’s dividend payout ratio is presently 28.49%.

Cardinal Health Company Profile

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.